Get notified when STOK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Auditor Change (new) — The company dismissed KPMG and replaced them with Ernst & Young, though the filing indicates no disagreements or reportable events occurred.
Stoke Therapeutics replaces auditor KPMG with Ernst & Young effective March 23, 2026
Filed March 27, 2026 · Period ending March 23, 2026 · ~1 min read
Key Changes
-
high
The Audit Committee dismissed KPMG as independent auditor and appointed Ernst & Young for fiscal year 2026, effective March 23. The company states there were no disagreements with KPMG on accounting principles or auditing procedures.
Item 4.01 verify on EDGAR → -
medium
KPMG's audit reports for 2024 and 2025 were clean with no adverse opinions, disclaimers, or qualifications, suggesting the auditor change was not driven by financial reporting disputes or issues.
Item 4.01 verify on EDGAR → -
medium
The company had not previously consulted with Ernst & Young on any accounting or auditing matters during the two most recent fiscal years prior to their appointment.
Item 4.01 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.
Partner
Trade STOK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify